ScholarIQanswers from OpenAlex & ORCID
Guido Gerken
ResearcherPublications, citations & collaboration network
Guido Gerken is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Guido Gerken have?
ScholarIQindexed works
Guido Gerken has 1,212 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Guido Gerken have?
ScholarIQcitation count
Guido Gerken has 35,031 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Guido Gerken?
ScholarIQh-index
Guido Gerken has an h-index of 94 in OpenAlex.
What is the i10-index of Guido Gerken?
ScholarIQi10-index
Guido Gerken has an i10-index of 422 in OpenAlex.
What is the ORCID of Guido Gerken?
ScholarIQorcid
The ORCID for Guido Gerken is on the source record.
What is the OpenAlex record for Guido Gerken?
ScholarIQopenalex
The OpenAlex for Guido Gerken is on the source record.
What are the most-cited papers on Guido Gerken?
ScholarIQmost cited works
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Andrew X. Zhu, Yoon‐Koo Kang, Chia‐Jui Yen, Richard S. Finn, Peter R. Galle, Josep M. Llovet, Eric Assénat, Giovanni Brandi, Marc Pracht, Ho Yeong Lim, Kun‐Ming Rau, Kenta Motomura, Izumi Ohno, Philippe Merle, Bruno Daniele, Dong Bok Shin, Guido Gerken, Christophe Borg, Jean‐Baptiste Hiriart, Takuji Okusaka, Manabu Morimoto, Yanzhi Hsu, Paolo Abada, Masatoshi Kudo
Non‐alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis
Judith Ertle, Alexander Dechêne, Jan‐Peter Sowa, Volker Penndorf, Kerstin Herzer, Gernot Kaiser, JF Schlaak, Guido Gerken, Wing‐Kin Syn, Ali Canbay
Albumin dialysis in cirrhosis with superimposed acute liver injury: A prospective, controlled study
Uwe Heemann, Ulrich Treichel, J. Loock, Thomas Philipp, Guido Gerken, Massimo Malagó, Sebastian Klammt, Matthias Loehr, S Liebe, Steffen Mitzner, R. Schmidt, Jan Stange
Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients
Sarah Berhane, Hidenori Toyoda, Toshifumi Tada, Takashi Kumada, Chiaki Kagebayashi, Shinji Satomura, Nóra Schweitzer, Arndt Vogel, Michael P. Manns, Julia Benckert, Thomas Berg, Maria Ebker, Jan Best, Alexander Dechêne, Guido Gerken, JF Schlaak, Arndt Weinmann, Marcus A. Wörns, Peter R. Galle, Winnie Yeo, Frankie Mo, Stephen L. Chan, Helen L. Reeves, Trevor F. Cox, Philip J. Johnson
GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis
Jan Best, Lars P. Bechmann, Jan‐Peter Sowa, Svenja Sydor, Alexander Dechêne, Kristina Pflanz, Sotiria Bedreli, Clemens Schotten, Andreas Geier, Thomas Berg, Janett Fischer, Arndt Vogel, Heike Bantel, Arndt Weinmann, Jörn M. Schattenberg, Yvonne Huber, Henning Wege, Johann von Felden, Kornelius Schulze, Dominik Bettinger, Robert Thimme, Friedrich Sinner, Kerstin Schütte, Karl Heinz Weiss, Hidenori Toyoda, Satoshi Yasuda, Takashi Kumada, Sarah Berhane, Marc Wichert, Dominik Heider, Guido Gerken, Philip J. Johnson, Ali Canbay